Miembros

José Luis Aceña

José Luis Aceña Bonilla

Associate Professor

ORCID iD iconorcid.org/0000-0002-1777-8199

  • Associate Professor, Universidad de Alcalá (2019–)
  • Assistant Professor, Universidad de Alcalá (2016–2019)
  • Interim Associate Professor, Universidad Autónoma de Madrid (2015–2016)
  • Part-time Professor, Universidad de Valencia (2012–2015)
  • Associated Researcher, Universidad del País Vasco (2012–2014)
  • Ramón y Cajal researcher, Centro de Investigación Príncipe Felipe, Valencia (2005–2011)
  • Senior Technician, Lilly, Madrid (2004)
  • Senior Chemist, PharmaMar, Madrid (2000–2003)
  • Postdoctoral researcher, Universidad de Cambridge (1997–2000)
  • Ph.D. Universidad Complutense de Madrid (1996)
  • Graduated at the Universidad Complutense de Madrid (1991)

After studying Chemistry at the Universidad Complutense de Madrid, he received his PhD from the same university with a thesis entitled “Synthesis of natural cyclitols and related compounds from 7-oxanorborne”. He then did a postdoctoral stay for two and a half years at the University of Cambridge, in the group of Prof. Ian Paterson. Back in Spain in 2000, he acquired professional experience in the pharmaceutical industry, and in 2005 he returned to the academic context, working successively in the groups of Prof. Santos Fustero at the Centro de Investigación Príncipe Felipe de Valencia (funded by the Ramón y Cajal programme), and Prof. Vadim Soloshonok at the Universidad del País Vasco.
Simultaneously, from September 2012 onwards, he has been teaching as a part-time Professor at the Universidad de Valencia. In the academic year 2014/2015 he was awarded a position as Interim Professor at the Universidad Autónoma de Madrid, and in October 2016 he was awarded a position as Assistant Professor at the Universidad de Alcalá. He is currently an Associate Professor at the Universidad de Alcalá.
Overall, his research over the last 25 years at the pre- and post-doctoral level has been focused on synthetic organic chemistry, with a clear trend towards the search and development of new compounds with biological activity. This has translated into a considerable scientific productivity: more than 80 publications, two patents and 28 communications in congresses. In addition, he has participated in fifteen research projects financed in public calls, being the main researcher in four of them. He has co-directed three Doctoral Thesis and eight Master Thesis.